1086
RESULTS: A patient developed a bilaterally symmetric bull's-eye maculopathy 45 years after taking quinacrine for 18 months as prophylaxis against malaria.
 A patient: Effect; bilaterally symmetric bull's-eye maculopathy: Effect; 45 years after taking quinacrine for 18 months: Treatment; 45 years after: Treatment.Time_elapsed; 18 months: Treatment.Time_elapsed; quinacrine: Treatment.Drug; malaria: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 A patient: Effect; bilaterally symmetric bull's-eye maculopathy: Effect; 45 years after taking quinacrine for 18 months: Treatment; 45 years after: Treatment.Time_elapsed; 18 months: Treatment.Time_elapsed; quinacrine: Treatment.Drug; malaria: Treatment.Disorder